Company / Operating Income
Bio-Rad Laboratories Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$47.2M
FY2025
5-year range
$47.2M / $500.3M
FY2021-FY2025
Trend
-82.5%
vs FY2024
Sector context
#88 of 156
Health Care
What the data says
At $47M, Bio-Rad Laboratories's operating income ranks #88 of 156 in the Health Care sector. Operating Income has declined for 4 consecutive years, from $500M in FY2021 to $47M in FY2025.
Based on SEC 10-K filings.
$47M in FY2025 with a 3-year CAGR of -53.9%.
Declined from $338M to $47M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -53.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 156 in Health CareTop 56% of 156This company $47.2M Sector average $733.1M
▼
-93.6% below sector average
Key checks
Key Insights
- Bio-Rad Laboratories's operating income has declined for 4 consecutive years.
- 3-year CAGR of -53.9%, indicating a declining trend.
- In FY2025, operating income decreased 82.5% year-over-year.
- Ranks #88 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.2M | -82.5% |
| FY2024 | $269.0M | -20.4% |
| FY2023 | $337.8M | -30.0% |
| FY2022 | $482.6M | -3.5% |
| FY2021 | $500.3M | +584.2% |
| FY2020 | -$103.3M | -145.0% |
| FY2019 | $229.7M | +312.2% |
| FY2018 | $55.7M | -66.6% |
| FY2017 | $166.7M | +11.2% |
| FY2016 | $150.0M | -10.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026